Archives
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Gastrin I (human): Precision CCK2 Receptor Agonist for Ga...
2026-03-15
Gastrin I (human) is a high-purity endogenous peptide used as a gastric acid secretion regulator and CCK2 receptor agonist. Its precise mechanism and solubility profile make it an essential tool for receptor-mediated signal transduction and gastrointestinal physiology studies. Controlled experiments confirm its robust performance in advanced in vitro and organoid models.
-
BIIE 0246 (SKU B6836): Enhancing NPY Y2 Receptor Assay Pr...
2026-03-14
This evidence-based guide addresses key laboratory challenges in neuropeptide Y (NPY) Y2 receptor research using BIIE 0246 (SKU B6836), a highly selective antagonist. We present scenario-driven Q&A blocks that illustrate how BIIE 0246 optimizes assay reproducibility, data interpretation, and experimental workflows for cell viability, proliferation, and cytotoxicity studies. Designed for biomedical researchers and lab technicians, this article delivers actionable strategies and references cutting-edge literature to support rigorous, translational science.
-
BIIE 0246: Selective Y2 Receptor Antagonist for Advanced ...
2026-03-13
BIIE 0246 is redefining precision in dissecting the neuropeptide Y signaling pathway, enabling breakthrough studies in feeding behavior, anxiety, and neurocardiac interactions. This article delivers actionable protocols, troubleshooting guidance, and comparative insights, positioning BIIE 0246 as the gold standard for targeted Y2 receptor inhibition in translational research.
-
GLP-1 (9-36) amide: Precision Antagonist for Human GLP-1 ...
2026-03-13
GLP-1 (9-36) amide is a rigorously validated peptide antagonist for the human GLP-1 receptor, enabling high-fidelity research in metabolic regulation and type 2 diabetes. This article details its biochemical properties, mechanism, and best practices for experimental use, highlighting its role as a standard in GLP-1 receptor signaling research.
-
Gastrin I (human): Mechanistic Insights and Next-Gen Stra...
2026-03-12
Explore the pivotal role of Gastrin I (human) as a gastric acid secretion regulator in advanced gastrointestinal physiology studies. This article delivers a mechanistic and methodological deep-dive, unveiling how this peptide transforms both fundamental research and high-fidelity in vitro modeling.
-
Parathyroid hormone (1-34) (human): Unraveling Precision ...
2026-03-12
Discover how Parathyroid hormone (1-34) (human) advances bone metabolism and serum calcium regulation through cutting-edge mechanistic insights. This article uniquely explores its integration with high-fidelity kidney disease modeling and experimental innovations.
-
GLP-1 (9-36) Amide: Unraveling Noncanonical GLP-1 Recepto...
2026-03-11
Explore how GLP-1 (9-36) amide, a cutting-edge GLP-1 receptor antagonist peptide, reveals noncanonical signaling and metabolic regulation mechanisms vital for type 2 diabetes research. This article offers a deeper mechanistic perspective and advanced application strategies beyond standard protocols.
-
2-Deoxy-D-glucose: Precision Glycolysis Inhibition for Tr...
2026-03-11
2-Deoxy-D-glucose (2-DG) stands out as a powerful glycolysis inhibitor, enabling targeted metabolic modulation in cancer, virology, and bone biology research. Backed by robust data and APExBIO’s consistent quality, 2-DG is the gold-standard tool for dissecting cellular energy pathways and enhancing experimental outcomes. Discover step-by-step workflows, advanced applications, and troubleshooting strategies to maximize your research impact.
-
BIIE 0246: Selective Neuropeptide Y Y2 Receptor Antagonis...
2026-03-10
BIIE 0246 is a potent, selective neuropeptide Y Y2 receptor antagonist that enables precise interrogation of presynaptic inhibitory effects and feeding behavior modulation in neuroscience research. Its nanomolar affinity, validated specificity, and reproducible pharmacological profile make it a gold-standard tool for dissecting neuropeptide Y signaling pathways.
-
GLP-1 (9-36) amide (SKU B5404): Practical Solutions for G...
2026-03-10
This scenario-driven guide addresses core laboratory challenges in GLP-1 receptor signaling and metabolic regulation research, focusing on the empirical advantages of GLP-1 (9-36) amide (SKU B5404). Drawing on validated protocols, high-throughput FRET data, and real-world product selection criteria, the article offers actionable solutions for reproducible cell-based assays and peptide antagonist workflow optimization.
-
2'3'-cGAMP (sodium salt): Transforming Cancer Immunothera...
2026-03-09
Explore how 2'3'-cGAMP (sodium salt) enables next-generation cancer immunotherapy by precisely activating the cGAS-STING signaling pathway. Delve into advanced delivery strategies and translational insights, uniquely highlighting its impact on tumor microenvironment modulation.
-
Precision Interrogation of the NPY/NPFF Axis in Translati...
2026-03-09
This thought-leadership article guides translational researchers through the latest mechanistic insights and strategic best practices for dissecting the neuropeptide Y (NPY) Y1 and neuropeptide FF (NPFF) receptor pathways. By leveraging BIBP 3226 trifluoroacetate—an advanced non-peptide antagonist—from APExBIO, the article integrates new evidence from the adipose-neural axis in cardiac arrhythmia, positions the compound within the evolving competitive landscape, and offers a forward-looking roadmap for innovation in anxiety, analgesia, and cardiovascular regulation research.
-
Parathyroid hormone (1-34) (human): Optimizing Kidney and...
2026-03-08
Parathyroid hormone (1-34) (human) unlocks advanced experimental control in both kidney assembloid and osteoporosis research, leveraging precise cAMP and inositol phosphate signaling. This guide spotlights detailed workflows, troubleshooting, and comparative insights that empower reproducible results and innovative modeling strategies.
-
Reproducible Cell Assays with Parathyroid hormone (1-34) ...
2026-03-07
This article addresses key laboratory hurdles in cell viability and kidney assembloid research, illustrating how Parathyroid hormone (1-34) (human) (SKU A1129) from APExBIO ensures reliable, high-fidelity results. Using scenario-based Q&A, we examine practical issues of assay design, data interpretation, and product selection, linking each to evidence-backed solutions and the unique strengths of A1129.
-
2-Deoxy-D-glucose (2-DG): Precision Glycolysis Inhibitor ...
2026-03-06
2-Deoxy-D-glucose (2-DG) is a validated glycolysis inhibitor widely used in metabolic pathway and cancer research. As a competitive inhibitor, it disrupts ATP synthesis, induces metabolic oxidative stress, and modulates immunometabolic signaling. This dossier provides machine-verifiable benchmarks and clarifies boundaries for effective deployment of 2-DG in research workflows.